Coordinate Regulation of Salmonella Virulence and Antimicrobial Resistance by MarR Transcription Factors
MarR 转录因子协调调节沙门氏菌毒力和抗菌素耐药性
基本信息
- 批准号:10624306
- 负责人:
- 金额:$ 49.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAntibiotic ResistanceAntibioticsAntimicrobial ResistanceBacteriaBacterial InfectionsBinding SitesDataDiseaseDrug EffluxDrug resistanceEvolutionFamilyGenesGeneticGenetic TranscriptionHealthHumanIn VitroLigandsLinkMetabolicMetabolismMetabolite InteractionMethodsMutationOperonPhenocopyPhenotypePreventionProteinsRegulationRegulonRepressionSalmonellaSalmonella infectionsSalmonella typhimuriumSignal TransductionTranscription RepressorVirulencebacterial metabolismcarboxylatecarboxylationcomparativeefflux pumpenteric pathogenin vivoinsightmetabolomicsnew therapeutic targetresponsetranscription factorvirulence gene
项目摘要
SUMMARY. MarR (Multiple antibiotic resistance Repressor) proteins comprise an ancient family of transcription
factors that are widely conserved in bacteria. In the enteric pathogen Salmonella Typhimurium, MarR is a
negative regulator of the AcrAB-TolC drug efflux pump, while another MarR transcription factor called SlyA is a
counter-silencer required for the expression of horizontally-acquired virulence genes. We have recently shown
that despite its divergent function, SlyA shares with MarR the ability to undergo allosteric modulation by aromatic
carboxylate molecules and can influence the mar phenotype by repressing the marRAB operon. Inactivation of
TolC, an essential component of the AcrAB and other RND-family efflux pumps, phenocopies a slyA mutation,
reducing the expression of Salmonella virulence genes. This suggests that efflux regulates the levels of an
endogenous metabolite that interacts with SlyA, which in turn controls MarR expression, completing a regulatory
circuit that coordinately links antimicrobial resistance, virulence, and bacterial metabolism.
This proposal investigates the hypothesis that Salmonella antimicrobial resistance and virulence are
coordinately regulated in response to metabolic signals by the MarR and SlyA transcription factors
through the following specific aims:
(1) Identification of endogenous ligand(s) that modulate MarR/SlyA activity. Preliminary data indicate that
SlyA-interacting ligand(s) are aromatic carboxylates. Specific endogenous ligands will be identified by genetic
and metabolomic methods and characterized with regard to affinity and allosteric inhibition.
(2) Functional characterization of MarR-SlyA-TolC regulatory interactions in Salmonella antimicrobial
resistance and virulence. The contribution of the MarR-SlyA regulatory network to Salmonella phenotypic
antimicrobial resistance and virulence will be assessed in vitro and in vivo.
(3) Comparative analysis of the MarR and SlyA regulons. MarR/SlyA-regulated genes and binding sites will
be comprehensively identified to determine the regulatory requirements for repression and counter-silencing,
respectively, and to elucidate the mechanisms of transcriptional network evolution.
These studies will provide important insights into a central regulatory network linking bacterial virulence, drug
resistance, and metabolism, which can lead to the identification of new therapeutic targets for the prevention or
treatment of bacterial infections.
概括。 MarR(多重抗生素耐药性阻遏蛋白)蛋白包含一个古老的转录家族
细菌中广泛保守的因子。在肠道病原体鼠伤寒沙门氏菌中,MarR 是一种
AcrAB-TolC 药物外排泵的负调节因子,而另一个称为 SlyA 的 MarR 转录因子是
水平获得性毒力基因表达所需的反沉默子。我们最近展示了
尽管其功能不同,SlyA 与 MarR 都具有通过芳香族化合物进行变构调节的能力
羧酸盐分子,并可以通过抑制 marRAB 操纵子来影响 mar 表型。失活
TolC 是 AcrAB 和其他 RND 家族外排泵的重要组成部分,可复制 slyA 突变,
减少沙门氏菌毒力基因的表达。这表明外排调节
与 SlyA 相互作用的内源代谢物,SlyA 反过来控制 MarR 表达,完成调节
协调连接抗菌素耐药性、毒力和细菌代谢的回路。
该提案研究了沙门氏菌抗菌素耐药性和毒力与沙门氏菌耐药性和毒力相关的假设。
MarR 和 SlyA 转录因子对代谢信号的协调调节
通过以下具体目标:
(1) 鉴定调节 MarR/SlyA 活性的内源配体。初步数据表明
SlyA 相互作用的配体是芳香族羧酸盐。特定的内源配体将通过遗传鉴定
和代谢组学方法,并以亲和力和变构抑制为特征。
(2) 沙门氏菌抗菌药物中 MarR-SlyA-TolC 调节相互作用的功能表征
抵抗力和毒力。 MarR-SlyA 调控网络对沙门氏菌表型的贡献
将在体外和体内评估抗菌药物耐药性和毒力。
(3)MarR和SlyA调节子的比较分析。 MarR/SlyA 调节的基因和结合位点将
全面识别以确定镇压和反沉默的监管要求,
分别,并阐明转录网络进化的机制。
这些研究将为连接细菌毒力、药物的中央监管网络提供重要见解。
抵抗力和代谢,这可以导致确定新的治疗靶点以预防或
治疗细菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ferric C Fang其他文献
Ferric C Fang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ferric C Fang', 18)}}的其他基金
Coordinate Regulation of Salmonella Virulence and Antimicrobial Resistance by MarR Transcription Factors
MarR 转录因子协调调节沙门氏菌毒力和抗菌素耐药性
- 批准号:
10415057 - 财政年份:2020
- 资助金额:
$ 49.47万 - 项目类别:
Regulation of S. aureus Colonization by NO.
NO 对金黄色葡萄球菌定殖的调节。
- 批准号:
9075111 - 财政年份:2016
- 资助金额:
$ 49.47万 - 项目类别:
Silencing and Counter-Silencing of Salmonella Virulence Genes
沙门氏菌毒力基因的沉默和反沉默
- 批准号:
8534704 - 财政年份:2012
- 资助金额:
$ 49.47万 - 项目类别:
Silencing and Counter-Silencing of Salmonella Virulence Genes
沙门氏菌毒力基因的沉默和反沉默
- 批准号:
8338998 - 财政年份:2012
- 资助金额:
$ 49.47万 - 项目类别:
相似国自然基金
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
- 批准号:32301424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向铜绿假单胞菌FpvA蛋白的铁载体偶联抗生素克服细菌耐药性及作用机制研究
- 批准号:82304313
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙醇脱氢酶AdhB介导肺炎链球菌抗生素耐药性的机制研究
- 批准号:32300154
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
鸭肠道菌群抗生素耐药性分布及替抗噬菌体内溶素鉴定研究
- 批准号:32360830
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
消毒剂-抗生素循环压力下鲍曼不动杆菌耐药性演变及其作用机制
- 批准号:82273586
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis
非结核分枝杆菌和 B 细胞在异位生发中心刺激和肺结核免疫控制中的作用
- 批准号:
10569865 - 财政年份:2023
- 资助金额:
$ 49.47万 - 项目类别:
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria
阳离子肽抗生素对粘菌素耐药菌活性的结构决定因素和机制
- 批准号:
10733264 - 财政年份:2023
- 资助金额:
$ 49.47万 - 项目类别:
Elucidation of the mechanisms of jumbophage genome protection during infection
阐明感染过程中巨噬细胞基因组保护机制
- 批准号:
10606835 - 财政年份:2023
- 资助金额:
$ 49.47万 - 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
- 批准号:
10603693 - 财政年份:2023
- 资助金额:
$ 49.47万 - 项目类别:
Dual-Stimuli Responsive Antibiotic-Loaded Nanoparticles: A New Strategy to Overcome Antimicrobial Resistance
双刺激响应抗生素负载纳米颗粒:克服抗生素耐药性的新策略
- 批准号:
10703696 - 财政年份:2023
- 资助金额:
$ 49.47万 - 项目类别: